Stay updated on Exenatide in Adolescent Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Exenatide in Adolescent Type 2 Diabetes Clinical Trial page.

Latest updates to the Exenatide in Adolescent Type 2 Diabetes Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA site-wide NIH notice about website updates and terminology changes is no longer displayed above the study page. The page still shows a 403 error.SummaryDifference1%

- Check14 days agoChange DetectedThe site footer now identifies revision v3.8.0 instead of v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.3%

- Check21 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe 403 Forbidden view was replaced by the ClinicalTrials.gov page shell, with navigation and footer visible and the revision updated to v3.7.2. Study details are not displayed.SummaryDifference0.6%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden message, replacing the previous study record view and blocking access to the study details and documents.SummaryDifference18%

Stay in the know with updates to Exenatide in Adolescent Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exenatide in Adolescent Type 2 Diabetes Clinical Trial page.